Focus Group Interview Study on Patient Experiences and Satisfaction

NCT ID: NCT04625842

Last Updated: 2024-05-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2020-09-01

Study Completion Date

2021-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In order to improve quality of care at the department, the investigators will perform a focus group interview study with patients and family members. They will perform 6 (3 in the French, and 3 in the Dutch language) focus group interviews with patients and 6 (3 in the French, and 3 in the Dutch language) with family members.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In order to improve quality of care at the department, the investigators will perform a focus group interview study with patients and family members. They will perform 6 (3 in the French, and 3 in the Dutch language) focus group interviews with patients and 6 (3 in the French, and 3 in the Dutch language) with family members. Following research questions will be answered:

* What elements of care (ie infrastructure, interpersonal contact, information, communication) are good to the opinion of patients and family members?
* What elements of care can be improved?
* What are priorities in improvement of the care for patients and families?
* What actions could possibly be taken in order to improve the care for future patients?

Because the radiotherapy ward exists of 3 clusters, one per type of treatment conducted, the investigators will perform 6 focus group interviews with patients (3 in the French, and 3 in the Dutch language) and 6 focus group interviews with family members (3 in the French, and 3 in the Dutch language).

Investigators will collect sex, main diagnosis (of patients), age and nationality of all participants at the beginning of each focus group interview. They will transcribe all interviews verbatim and analyze them in Nvivo software as provided by the VUB. Participant characteristics will be analyzed by descriptive statistics.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Patient Satisfaction Patient Preference

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Focus group interview study
Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patient focus group

Patients who received radiation treatment

Group Type EXPERIMENTAL

Focus group interview

Intervention Type OTHER

Group interview with patients who received radiation treatment

Family focus group

Family of patients who received radiation treatment

Group Type EXPERIMENTAL

Focus group interview

Intervention Type OTHER

Group interview with patients who received radiation treatment

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Focus group interview

Group interview with patients who received radiation treatment

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients (18+) who were treated for cancer, receiving radiotherapy, and followed thereafter in the UZ Brussel
* Dutch and French speaking
* Start date of treatment max 6 months before inclusion
* Estimated sample size: 5-8 x 6 patients


* All family members (+18) of patients who were treated for cancer, receiving radiotherapy, and followed thereafter in the UZ Brussel
* Dutch and French speaking
* Start date of treatment of patient max 6 months before inclusion
* Estimated sample size: 5-8 x 6 family members
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universitair Ziekenhuis Brussel

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mark De Ridder

Professor in oncology

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UZ Brussel

Brussels, , Belgium

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2020-087

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Pain in Cancer Survivors
NCT00581724 COMPLETED